טוען...
Inhibition of herpes simplex virus type 1 replication by novel hsa-miR-7704 in vitro
Herpes simplex virus type 1 (HSV-1) infections are one of the most common diseases in human population. HSV-1 causes subclinical, mild to severe diseases, especially in immunocompromised patients. Acyclovir has been used to reduce manifestations of HSV-1 infections. The extensive use of this drug ha...
שמור ב:
| הוצא לאור ב: | Res Pharm Sci |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer - Medknow
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791169/ https://ncbi.nlm.nih.gov/pubmed/31620193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.253364 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|